Form 4 for URGN UroGen Pharma Ltd.
Accepted 2021-12-02 00:00:00 ET · period of report 2021-11-30 · accession 0001209191-21-067440 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2021-12-02 | 2021-11-30 | URGN | Smith Jason Drew | GC | M - OptEx | — | +8,333 | 10.8K | +333% | — |
| D | 2021-12-02 | 2021-11-30 | URGN | Smith Jason Drew | GC | S - Sale+OE | $12.03 | -3,803 | 7,030 | -35% | -$45.8K |
| D | 2021-12-02 | 2021-11-30 | URGN | Smith Jason Drew | GC | M - OptEx | $0.00 | -8,333 | 16.7K | -33% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Ordinary Shares | 2021-11-30 | M | A | 8,333 | — | 10,833 | D | — | — | (F1) Each restricted stock unit ("RSU") represents a contingent right to receive one ordinary share of the Issuer |
| 2 | Common | Ordinary Shares | 2021-11-30 | S | D | 3,803 | $12.03 | 7,030 | D | — | — | (F2) Represents shares sold to satisfy withholding tax obligations upon the settlement of restricted stock units |
| 3 | Derivative | Restricted Stock Units | 2021-11-30 | M | D | 8,333 | $0.00 | 16,667 | D | — · — to — | 8,333 Ordinary Shares | (F1) Each restricted stock unit ("RSU") represents a contingent right to receive one ordinary share of the Issuer (F3) 1/3 of the shares underlying the restricted stock units will vest on each of November 30, 2021, August 31, 2022 and August 31, 2023. |